Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets open in 7 hours 20 minutes
NIKKEI 225
38,274.05
-131.61
(-0.34%)
HANG SENG
17,763.03
+16.12
(+0.09%)
CRUDE OIL
79.06
+0.06
(+0.08%)
GOLD FUTURES
2,331.70
+20.70
(+0.90%)
DOW
37,903.29
+87.37
(+0.23%)
Bitcoin GBP
46,371.62
-1,972.61
(-4.08%)
Money
Family finances
Who is the breadwinner in your family and does it matter?
Fate Therapeutics, Inc. (FATE)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
4.0900
+0.1400
(+3.54%)
At close: 04:00PM EDT
3.9800
-0.11
(-2.69%)
After hours:
07:30PM EDT
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
63,533
63,533
96,300
55,846
31,434
Operating expenses
Research development
172,596
172,596
320,454
215,519
125,623
Selling general and administrative
81,448
81,448
84,232
57,321
33,896
Total operating expenses
254,044
254,044
404,686
272,840
159,519
Operating income or loss
-190,511
-190,511
-308,386
-216,994
-128,085
Interest expense
-
-
-
0
0
Total other income/expenses net
12,397
12,397
20,823
3,534
-47,702
Income before tax
-160,928
-160,928
-281,721
-212,151
-173,387
Income from continuing operations
-160,928
-160,928
-281,721
-212,151
-173,387
Net income
-160,928
-160,928
-281,721
-212,151
-173,387
Net income available to common shareholders
-160,928
-160,928
-281,721
-212,151
-173,387
Basic EPS
-1.77
-1.64
-2.91
-2.24
-2.10
Diluted EPS
-1.77
-1.64
-2.91
-2.24
-2.10
Basic average shares
98,064
98,411
96,826
94,747
82,385
Diluted average shares
98,064
98,411
96,826
94,747
82,385
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.